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Serine hydroxymethyltransferase (SHMT), a pyridoxal 5«-phos-
phate (PLP)-dependent enzyme, catalyses the transfer of the
hydroxymethyl group from serine to tetrahydrofolate to yield
glycine and N &,N"!-methylenetetrahydrofolate. An analysis of
the known SHMT sequences indicated that several amino acid
residueswere conserved. In this paper, we report the identification
of the amino acid residues essential formaintaining the oligomeric
structure of sheep liver cytosolic recombinant SHMT (scSHMT)
through intra- and inter-subunit interactions and by stabilizing
the binding of PLP at the active site. The mutation of Lys-71,
Arg-80 and Asp-89, the residues involved in intra-subunit ionic
interactions, disturbed the oligomeric structure and caused a loss
of catalytic activity. Mutation of Trp-110 to Phe was without
effect, while its mutation to Ala resulted in the enzyme being
present in the insoluble fraction. These results suggested that
INTRODUCTION
Serine hydroxymethyltransferase (SHMT) catalyses a key step
linking amino acid and nucleotide metabolism. It transfers the
hydroxymethyl group of l-Ser to 5,6,7,8-tetrahydrofolate (H
%
-
folate) to yield Gly and 5,10-methylene-H
%
-folate, an important
intermediate in amino acid and nucleotide metabolism [1,2]. It
serves as a source for 1-carbon fragments for a variety of end
products. SHMT has been suggested as a potential target for
cancer chemotherapy [3–6]. The gene for the enzyme has been
isolated from a variety of pro- and eu-karyotic sources and
overexpressed in Escherichia coli (reviewed by Appaji Rao et al.
[6]). It was considered worthwhile to examine all the sequences of
SHMT (http:}}www.ncbi.nlm.nih.gov}Entrez}) and identify the
conserved residues with functional group(s) that could participate
in catalysis or pair with an oppositely charged residue to stabilize
the structure. The availability of the three-dimensional structures
of SHMT from three eukaryotic [5,7,8] and two prokaryotic
[9,10] sources could facilitate an understanding of the role of
some of these residues in the structure and function of SHMT.
This paper describes an analysis of mutation of several conserved
amino acid residues essential for maintaining the oligomeric
structure of the sheep liver cytosolic recombinant SHMT
(scSHMT). The results suggest that the mutation of crucial
residues involved in either intra- or inter-subunit interactions or
in pyridoxal 5«-phosphate (PLP) binding cause disruption of the
tetrameric structure, loss of PLP and a consequent decrease in
catalytic activity.
Abbreviations used: SHMT, serine hydroxymethyltransferase; scSHMT, sheep liver cytosolic recombinant SHMT; hcSHMT, human liver cytosolic
recombinant SHMT; PLP, pyridoxal 5«-phosphate ; H4-folate, 5,6,7,8-tetrahydrofolate.
1 Present address : 4E, James Graham Brown Cancer Center, 529 S Jackson Street, University of Louisville, Louisville 40202, KY, U.S.A.
2 To whom correspondence should be addressed (e-mail bchss!biochem.iisc.ernet.in).
Trp-110 located in a cluster of hydrophobic residues was essential
for proper folding of the enzyme. Arg-98 and His-304, residues
involved in the inter-subunit interactions, were essential for
maintaining the tetrameric structure. Mutation of Tyr-72, Asp-
227 and His-356 at the active site which interact with PLP
resulted in the loss of PLP, and hence loss of tetrameric structure.
Mutation of Cys-203, located away from the active site, weakened
PLP binding indirectly. The results demonstrate that in addition
to residues involved in inter-subunit interactions, those involved
in PLP binding and intra-subunit interactions also affect the
oligomeric structure of scSHMT.
Key words: oligomeric structure, pyridoxal 5«-phosphate, se-
quence comparison, site-directed mutagenesis, subunit inter-
action.
EXPERIMENTAL
Materials
[a-$#P]dATP (3000 Ci}mmol) was obtained from the Board of
Radiation and Isotope Technology, Government of India,
Trombay, India. l-[3-"%C]Ser, restriction endonucleases,
SequenaseTM version 2.0 sequencing kit and DNA-modifying
enzymes were obtained from Amersham Biosciences (Little
Chalfont, Bucks., U.K.). Deep Vent polymerase was purchased
from New England Biolabs (Beverly, MA, U.S.A.). CM-
Sephadex, Sephacryl S-200, Gly, l-Ser, d-Ala, 2-mercapto-
ethanol, folic acid, PLP, isopropyl b-d-thiogalactoside and
EDTA were obtained from Sigma (St. Louis, MO, U.S.A.).
Platinum oxide was purchased from Loba Chemie (Mumbai,
India). Centricon filters were obtained from Amicon (Millipore,
Beverly, MA, U.S.A.). All other chemicals were of analytical-
reagent grade. The mutant oligonucleotides were purchased
from Bangalore Genei Pvt. (Bangalore, India). H
%
-Folate was
prepared as described by Hatefi et al. [11].
Bacterial strains, growth conditions and DNA manipulations
E. coli strain DH5a (Bethesda Research Labs, Bethesda, MD,
U.S.A.) was the recipient of all the plasmids used for DNA
isolation and subcloning. E. coli BL21(DE3) pLysS strain [12]
was used for the expression of scSHMT [13] and the mutant
SHMT clones. Luria–Bertani medium or terrific broth (24 g of
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yeast extract, 12 g of tryptophan, 4 ml of glycerol, 2.31 g of
KH
#
PO
%
and 12.54 g of K
#
HPO
%
}l) with 50 lg}ml ampicillin was
used to grow E. coli cells containing the plasmids at 37 °C.
Plasmids were prepared by the alkaline lysis procedure described
by Sambrook et al. [14]. The DNA fragments were eluted from
low-melting-point agarose gels after electrophoresis [15].
The co-ordinates for human liver cytosolic recombinant
SHMT (hcSHMT; PDB code 1BJ4) [5] were analysed using the
PROCHECK program to evaluate the secondary structure and
accessibility (results not shown). These data were used to describe
the position of the residues mutated in this study.
Site-directed mutagenesis
The R80A, D89N, R98A, W110A, W110F and C203S mutants
were constructed by a PCR-based megaprimer method [15–17].
The first PCR product (megaprimer) was obtained using the
mutant oligonucleotide and M13 (fi24) universal reverse primer
(5«-GGAAACAGCTATGACCATG-3«). pUCSH (pUC19 con-
taining the SHMT cDNA fragment lacking 227 bp at the 5« end)
was used as a template. The full-length PCR product was
obtained using three primers, i.e. the megaprimer (first PCR
product), SHP1 (5«-TATGGCAGCTCCAGTCAAC-3«, at the
start of the gene) and the M13 (fi24) universal reverse primer
using pETSH (containing a full-length cDNA for SHMT [13]),
as a template. The full-length PCR product, obtained after two
rounds of PCR, was subcloned into pUC19 at the KpnI and
BamHI sites. This clone was digested with KpnI and PmacI
restriction enzymes to obtain the 520 bp fragment. The entire
520 bp fragment was sequenced using the SequenaseTM version
2.0 DNA sequencing kit to confirm the presence of the mutation
and to rule out the presence of non-specific mutations. The
520 bp fragment containing the mutated region was gel-purified
and swapped with the wild-type clone, i.e. pETSH, and the
mutation was reconfirmed by sequencing the expression con-
struct.
The other mutants used in the study were constructed using
the sense}antisense primer method as described earlier [18].
Briefly, the wild-type template (pRSH; 80 ng), and sense and
antisense primers (50 pmol) were added to PCR tubes containing
0.4 mM dNTPs, 1 mM MgSO
%
and 2.5 units of Deep Vent DNA
polymerase along with the buffer provided with the enzyme at
1‹concentration. The amplification reaction was carried out in
a PerkinElmer PCR machine using the following cycling
conditions: denaturation of the template at 95 °C for 4 min
followed by 20 cycles at 94 °C for 45 s (denaturation), 52 °C for
1 min (annealing) and 72 °C for 5 min (extension). The reaction
was continued for 20 min at 72 °C to complete the extension. The
PCR-amplified mixture was treated with DpnI (10 units) at 37 °C
for 1 h to digest the methylated DNA (template DNA) and
transformed into DH5a competent cells. The presence of the
mutation was confirmed by sequencing the plasmid DNA by
Sanger’s dideoxy chain-termination method [19] using
SequenaseTM version 2.0 (results not shown) or by ABI Prism
automated DNA sequencer. K71Q, Y72F, Y81F, S202C and
D227N were constructed using this procedure.
The H304A, H306A and H356A mutants were constructed
using the sense}antisense primer method with minor modi-
fications. The megaprimer (obtained by PCR using the mutant
oligonucleotide and SHM1, 5«-TATCATGAAGCCAGGCAG-
G-3«, the C-terminal primer of the full-length SHMT gene) was
used as sense and antisense primers on pRSH template. The
mutant oligonucleotides used to construct site-specific mutants
are given below: R80A, 5«-AC CCA GGC CAG GCC TAC
TAT GGT GGG-3« ; D89N, 5«-GA ATT CAT CAA TGA GCT
AGA G-3« ; R98A, 5«-TC TGT CAG AAG GCA GCG CTG
CAG G-3« ; W110A, 5«-G GAC CCC GAG TGC GCG GGG
GTT AAC G-3« ; W110F, 5«-TG GAC CCC GAG TGC TTC
GGG GTT AAC G-3« ; C203S, 5«-GGG ACT AGC TCC TAC
TCC CG-3« ; H304A, 5«-AA GGG GGA CCG GCC AAC CAC
GCC ATT-3« ; H306A, 5«-GA CCT CAC AAC GCC GCC ATT
GCT G-3« ; H356A, 5«-TCT GAC AAC GCA TTA ATC CTC
GTG GAC-3« ; K71Q (sense), 5«-CTG AAC AAC CAG TAC
TCT GAG-3« ; K71Q (antisense), 5«-CTC AGA GTA CTG GTT
GTT CAG-3« ; Y72F (sense), 5«-AAC AAC AAG TTC TCT
GAG GGG-3« ; Y72F (antisense), 5«-CCC CTC AGA GAA
CTT GTT GTT-3« ; S202C (sense), 5«-GCA GGG ACT TTG
TGC TAC TCC-3« ; S202C (antisense) 5«-GGA GTA GCA CAA
AGT CCC TGC-3« ; D227N (sense), 5«-CTC ATG GCT AAC
ATG GCA CAT-3« ; D227N (antisense), 5«-ATG TGC CAT
GTT AGC CAT GAG-3«.
Expression and purification of mutant enzymes
pETSH and mutant plasmids were transformed into the E. coli
BL21(DE3) pLysS strain. scSHMT and mutants were grown at
30 °C and purified using the protocol standardized for scSHMT
earlier [18,20]. The enzyme pellet was dialysed against buffer A
(50 mM potassium phosphate buffer, pH 7.4}1 mM 2-
mercaptoethanol}1 mM EDTA) for 24 h with two changes
(1 litre) prior to use. Protein was estimated by the method of
Lowry et al. [21].
Enzyme assays
Hydroxymethyltransferase reaction
The SHMT-catalysed aldol cleavage of l-Ser with H
%
-folate
to form Gly and 5,10-CH
#
-H
%
-folate was monitored using
l-[3-"%C]Ser and H
%
-folate as substrates as described earlier
[22,23]. The reaction mixture (0.1 ml) contained 400 mM pot-
assium phosphate buffer, pH 7.4, 1.8 mM dithiothreitol, 1 mM
EDTA, 50 lM PLP, 1.8 mM H
%
-folate, 3.6 mM l-Ser and an
appropriate amount of the enzyme (determined in each case from
an enzyme concentration versus velocity curve at different con-
centrations of the mutant or wild-type enzyme). A time course of
the reaction was measured in all cases to ensure that the initial
velocity was determined. One unit of enzyme activity was defined
as the amount of enzyme that catalysed the formation of 1 lmol
of formaldehyde by the decomposition of 5,10-CH
#
-H
%
-folate}
min at 37 °C and pH 7.4. The specific activity was expressed as
units}mg of protein. For the determination of K
m
and k
cat
values,
the assay was carried out at various concentrations of l-Ser
(0–4 mM) after ensuring that the initial velocity was being
measured, and the kinetic parameters were calculated by non-
linear regression analysis using Sigmaplot software.
Transaminase activity
SHMT catalyses the transamination of d-Ala to give pyruvate
and the bound PLP is converted into pyridoxamine phosphate
[24]. scSHMT and mutants were taken separately in 900 ll of
buffer A and absorbance was measured at 425 nm against the
same buffer blank in a Shimadzu UV-160A spectrophotometer
after pre-incubation at 37 °C for 3 min. The reaction was started
by the addition of 100 ll of 1 M d-Ala to both the cuvettes.
Absorbance change at 425 nm was monitored with increasing
periods of incubation and the pseudo-first-order rate constants
were calculated as described earlier [20].
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Spectroscopic methods
Absorption spectra
Absorption spectra of the enzyme preparations were recorded
with a Shimadzu UV-160A spectrophotometer in buffer A. The
spectra were recorded at 25‡2 °C against buffer A and a con-
centration of 1 mg of protein}ml was used in all cases.
Far-UV CD measurements
Far-UV CD spectral measurements were made in a Jasco J-500A
spectropolarimeter using a cuvette of 1 mm pathlength. The
spectra were recorded at 25‡2 °C in buffer A (Millipore-filtered)
from 250 to 195 nm using 0.5 lM SHMT. The data were plotted
as molar ellipticity (h
ME
) assuming a relative subunit molecular
mass of 52900 Da for scSHMT and the site-specific mutants :
h
ME
fl (h‹100‹M
r
)}C‹d (1)
where h is the observed molar ellipticity (in degrees), M
r
is the
subunit molecular mass, C is the concentration of protein in
mg}ml and d is the pathlength in decimetres.
Preparation of the apo-enzyme
Apo-enzyme of SHMT was prepared as described earlier [24]
with minor modifications. d-Ala (200 mM) was added to the
holo-enzyme in 50 mM potassium phosphate buffer, pH 7.4,
containing 1 mM 2-mercaptoethanol, 1 mM EDTA and 200 mM
(NH
%
)
#
SO
%
, and incubated at 37 °C for 4 h. The reaction mixture
was rapidly dialysed in a Centricon tube at 4 °C for 1 h using
buffer A, but not containing PLP. The pyruvate and pyridox-
amine phosphate formed in the reaction were removed by this
procedure and the apo-enzyme had no absorbance at 425 nm.
Size-exclusion chromatography
The native molecular masses of scSHMT and the site-specific
mutant enzymes were determined using a Superose-12 HR 10}30
analytical gel-filtration column attached to an Amersham Bio-
sciences FPLC system. The column was equilibrated with buffer
A (with or without PLP) and calibrated with standard molecular-
mass markers, i.e. apoferritin (440000 Da), b-amylase
(200000 Da), yeast alcohol dehydrogenase (150000 Da), BSA
(66000 Da) and carbonic anhydrase (29000 Da). The protein
peaks were monitored by measuring the absorbance at 280 nm.
RESULTS
Analysis of sequences of SHMTs to identify conserved residues
A commendable job of aligning the sequences of a-class PLP
enzymes, to which SHMT belongs, has been carried out by
Grishin et al. [25]. In the present study, we have compared 55
sequences of SHMT (28 from prokaryotes, 17 from eukaryotes
and 10 from archeabacteria) using FASTA program (GCG
package). A total of 60 amino acid residues are completely
conserved between at least 54 of the known sequences of SHMT.
Among these, there are several conserved amino acid residues
with polar functional groups, which could participate in catalysis
or in stabilizing the structure. A list of such conserved residues is
given in Table 1. Some of these residues were mutated and
characterized earlier. The properties of the following mutants of
scSHMT are described and discussed in this paper : K71Q,
Y72F, R80A, D89N, R98A, W110A, W110F, S202C, C203S,
D227N, H304A, H306A and H356A.
Table 1 Highly conserved functional residues in 55 SHMT sequences
The numbers in bold represent the amino acids mutated in this study.
Amino acid
Residue number
(based on scSHMT)
Arginine 80, 98, 262, 401
Aspartate 89, 227
Glutamate 39, 74, 92
Histidine 147, 150, 230, 304, 306, 356
Lysine 71, 256
Serine 52, 118, 202
Threonine 251, 252, 253, 254, 257
Tyrosine 72, 82, 204
Tryptophan 110
Figure 1 Representative far-UV CD spectra of scSHMT and its mutants
The spectra were recorded in the range 195–250 nm using a Jasco J-500A spectropolarimeter
using 100 lg/ml scSHMT or its mutants. Solid line, holo-scSHMT (tetramer) ; broken line,
R80A (dimer) ; dotted line, Y72F (a mixture of dimer and tetramer). Similar spectra were
obtained with K71Q, W110F, S202A, C203S, H304A, H306A and H356A scSHMT (data is not
shown).
Properties of the mutant enzymes
scSHMT and the mutant enzymes were overexpressed and the
recombinant enzymes were purified as described in the Ex-
perimental section. Figure 1 shows the far-UV CD spectra of
scSHMT, R80A and Y72F, typical of a tetramer, dimer or
mixture of tetramer and dimer, respectively. All the other mutants
discussed in this study gave similar results (not shown). The far-
UV CD spectrum of mutants was identical with that of the wild-
type enzyme, suggesting that there were no changes in the
secondary structure due to the mutation(s) (Figure 1).
The specific activities and the kinetic parameters of H
%
-folate-
dependent hydroxymethyltransferase reaction catalysed by the
mutant enzymes are listed in Table 2. It can be seen from Table
2 that there was near-complete loss of activity in K71Q, R80A,
H304A and D227N SHMT mutants, a partial loss of activity
in Y72F, S202C, H306A and H356A and no loss of activity in
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Table 2 The kinetic properties of scSHMT and its mutant enzymes
Specific activity is given as lmol of HCHO formed/min per mg of protein at 37 °C and pH 7.4. The kinetic parameters were determined from six independent estimations using non-linear regression
analysis, employing Sigmaplot software. ND, not determined as the activity was very low or the enzyme could not be solubilized.
Enzyme Specific activity Km (mM) kcat per subunit (s−
1) kcat/Km (mM [ s−
1)
scSHMT 4.2‡0.1 0.93‡0.13 4.08‡0.2 4.39
K71Q 0.0002 ND ND ND
Y72F 0.032‡0.02 0.99‡0.23 0.06‡0.02 0.06
R80A 0.0002 ND ND ND
R98A ND (insoluble) ND ND ND
W110A ND (insoluble) ND ND ND
W110F 4.3‡0.1 0.94‡0.14 4.42‡0.18 4.7
S202C 0.2‡.01 ND ND ND
C203S 4.2‡0.2 1.03‡0.15 3.32‡0.35 3.2
D227N 0.0002 ND ND ND
H304A 0.0004 ND ND ND
H306A 1.88‡0.1 0.58‡0.25 3.1‡0.25 5.3
H356A 0.82‡0.15 0.94‡0.01 1.6‡0.24 1.7
Table 3 The oligomeric structure and PLP content of scSHMT and its
mutants
PLP content was determined using a molar absorption coefficient of 6600 M−1 for PLP. The
errors were calculated from four different enzyme preparations. The retention volumes were
determined using a calibrated Superose 12 column, and are means from at least two
independent preparations. The volume 10.1 ml corresponds to the tetramer molecular mass
(approx. 210 kDa) and 11.1 ml corresponds to the dimer molecular mass of approx. 110 kDa.
ND, not determined as they were present in the insoluble fraction.
Enzyme
PLP content
(lmol/subunit)
Holo-enzyme
(retention volume ; ml)
ScSHMT 0.9‡0.2 10.1
K71Q 0 11.2
Y72F 0.11 10.1, 11.2
R80A 0 11.1
Y81F 1.0‡0.1 10.2
R98A ND ND
W110A ND ND
W110F 1.1‡0.2 10.1
S202C 0.2‡0.05 10.1, 11.2
C203S 0.98‡0.1 10.2
D227N 0 11.2
H304A 0 11.2
H306A 0.53‡0.15 10.1, 11.2
H356A 0.63‡0.15 10.1, 11.2
C203S and W110F (Table 2). In the case of W110A and R98A
SHMT, although good expression was observed, the mutant
proteins were present in the insoluble fraction. All attempts at
solubilizing the expressed proteins were unsuccessful. It can be
seen from Table 2 that the mutations which led to partial loss of
activity did not cause a change in the K
m
value for l-Ser,
although the k
cat
and specific activity values were altered, thereby
affecting the catalytic efficiency of the mutant enzymes (Table 2).
Physico-chemical properties of scSHMT and its mutants
scSHMT and all the mutants listed in Table 2 gave a single band
with a molecular mass of 53 kDa on SDS}PAGE (results not
shown). scSHMT gave a single symmetrical peak with a retention
volume of 10.1 ml upon FPLC using a calibrated Superose 12
column (Table 3 and Figure 2), which confirmed that scSHMT
is a tetramer with a molecular mass of 210 kDa (Figure 2, trace
a). C203S and W110F SHMT mutants behaved in an identical
Figure 2 Size-exclusion chromatography profiles of scSHMT and its
mutants
The wild-type and mutant SHMT enzymes (150 lg) were loaded on to a Superose 12 size-
exclusion chromatography column attached to an Amersham Biosciences FPLC system with an
online UV detector. The column was calibrated using standard protein molecular-mass markers
(see the Experimental section). The column was equilibrated with buffer A with or without PLP
prior to the experiments. The flow rate was 1 ml/min. Trace a, scSHMT (tetramer) ; trace b,
R80A SHMT (dimer) ; trace c, Y72F (a mixture of dimer and tetramer).
manner, showing that they were tetramers (Table 3). On the
other hand, Y72F, S202C, H306A and H356A gave two peaks
(retention volume, 10.1 and 11.2 ml) corresponding to dimer and
tetramer (Table 3; data only for Y72F is presented in Figure 2).
The percentages of dimer and tetramer in mutants Y72F, Y81F,
S202C, H306A and H356A were 30:70, 20:80, 55:45, 60:40 and
80:20 (calculated from the area under the peaks upon gel-
filtration analysis similar to that described in Figure 2, trace c, for
Y72F) respectively. Gel filtration at different KCl concentrations
up to 1 M did not alter the shape of the elution patterns or the
area under the peaks. On the other hand, K71Q, R80A, H304A
and D227N eluted as a single symmetrical peak corresponding to
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Figure 3 Absorbance spectra of scSHMT and its mutants
The visible absorbance spectra of the enzymes (1 mg/ml) in buffer A recorded on a Shimazdu
UV/visible spectrophotometer from 350 to 500 nm at 25 °C. Trace a, scSHMT (tetramer) ; trace
b, R80A SHMT (dimer) ; trace c, Y72F (a mixture of dimer and tetramer).
a dimer (Table 3 and Figure 2, trace b; data are shown for R80A
only). A peak corresponding to a monomer was not seen with
scSHMT or its mutants under any of the experimental conditions
described above (results not shown).
The visible absorbance spectra of scSHMT and its mutants
showed that the mutations caused no, partial or complete loss of
PLP (Figure 3). The amount of PLP was calculated using a molar
absorption coefficient of 6600 M−" and is shown in Table 3 for all
the enzymes. The concentration of PLP in scSHMT and its
mutants correlated very well with the oligomeric status and
percentage of dimer (no PLP) and tetramer in some of the
mutant enzymes (results not shown).
DISCUSSION
The three-dimensional structures of the a-class of PLP-dependent
enzymes are remarkably similar [5]. The availability of the crystal
structures of hcSHMT [5], rabbit liver cytosolic recombinant
SHMT [7], murine liver cytosolic recombinant SHMT [8], E. coli
recombinant SHMT [9] and Bacillus stearothermophilus recom-
binant SHMT [10] has enabled a more critical examination of the
role of amino acids in the structure and function of SHMT.
The three-dimensional structures of SHMTs can be overlaid on
each other to a large extent ; SHMT is a highly conserved protein
[26]. For these reasons, drawing analogies from hcSHMT’s
structure [5] to explain the observations with scSHMT is justified.
Intra-subunit interactions stabilizing the tetrameric structure of
scSHMT
The N-terminal methionine residue is cleaved during expression
of the scSHMT gene in E. coli. For this reason, there is a
difference of one residue in the numbering of scSHMT and
hcSHMT. For example, D89N in scSHMT is equivalent to D90N
in hcSHMT.
Asp-89 and Arg-80
In an earlier study it was shown that the mutation of Asp-89 to
Asn in scSHMT lead to the formation of a mixture of dimers and
tetramers [17]. The tetramer of D89N SHMT was fully active
when isolated in the presence of excess PLP (500 lM). However
the apo-enzyme, prepared by removal of PLP [24], and which was
present only as a dimer, could not be reconstituted by addition
of PLP [17]. Asp-89 interacts only with Arg-80 and it has no
additional interactions and therefore the effect of this mutation
was mild. An examination of the position of Arg-81 in the
hcSHMT crystal structure (Arg-80 in scSHMT) revealed that
this residue is positioned in b-sheet 2 and stabilizes a-helix 4 by
the following interactions. (i) The guanidino NH1 group of the
Arg-81 is within hydrogen-bonding distance of the carbonyl
group of the main polypeptide chain and the hydroxy group of
Ser-74 (Ser-73 in scSHMT). (ii) The second NH2 group is within
hydrogen-bonding distance of the carbonyl group of Glu-93
(Glu-92 in scSHMT) and Asp-90 (Asp-89 in scSHMT; Figure
4a). It is therefore not surprising that the mutation of Arg-80 to
Ala (in scSHMT) resulted in a dislocation of multiple inter-
actions. This lead to a drastic effect on the enzyme architecture,
resulting in disruption of the tetrameric structure to a near-
complete loss of enzyme activity and ability to bind PLP (Tables
2 and 3 and Figures 2 and 3).
Lys-71
In addition to Lys-256 in scSHMT (Lys-257 in hcSHMT), which
anchors PLP, another Lys residue, Lys-71 in scSHMT (Lys-72 in
hcSHMT) is located close to the active site. Lys-72 of hcSHMT
stabilizes the tetrameric structure by interacting with the carbonyl
group of a peptide bond involving Gly-84 and Gly-85 in hcSHMT
(Gly-83 and Gly-84 in scSHMT; not shown) [27]. These inter-
actions stabilize the intra-subunit interactions, which enable
generation of the correct geometry for the binding of PLP at
the active site. Mutation of the corresponding residue in
scSHMT, Lys-71 to Gln, resulted in the formation of inactive
dimers (Tables 2 and 3). These results once again emphasize
the importance of intra-subunit interactions in maintaining the
oligomeric structure of the enzyme.
Trp-110
Chemical modification studies had indicated that Trp residues
were essential for the activity of the hcSHMT [28]. Trp-111 in
hcSHMT is located at the beginning of b-sheet 4. The mutation
of the corresponding residue, Trp-110, in scSHMT to Ala resulted
in the enzyme being present in the insoluble fraction (Table 2).
Trp-110 is conserved in all eukaryotic enzymes, whereas this is not
the case in prokaryotes. An examination of the three-dimensional
structure of hcSHMT revealed that Trp-111 was surrounded by
hydrophobic residues Leu-106, Phe-245 and Phe-268 (Figure 4b).
It is therefore possible that the mutation of Trp-110 to Ala in
scSHMT disturbs this hydrophobic pocket, which is crucial for
the proper folding of the enzyme. This suggestion was confirmed
by the mutation of Trp-110 to Phe. The W110F SHMT mutant
had properties similar to the wild-type enzyme (Tables 2 and 3).
It also generated a geminal diamine with Gly and a quinonoid
intermediate upon the addition of Gly and H
%
-folate, as in the
wild-type enzyme (results not shown) [13].
Inter-subunit interactions stabilizing the tetrameric structure
Arg-98 and Asp-29
Arg-98 of scSHMT is conserved in all eukaryotic SHMTs and in
21 out of 28 prokaryotic sequences (Table 1). The corresponding
residue Arg-99 in hcSHMT is located at a-helix 4 and interacts
with Asp-30 (located at a-helix 2) of the neighbouring subunit
(across the subunits of the tight dimer; Figure 4c). In theory, this
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Figure 4 Residues involved in the intra-subunit interactions
The diagrams were generated using Insight II 97.2 software using hcSHMT co-ordinates (PDB code 1BJ4). Grey-coloured helix indicates the A subunit and black indicates the D subunit ; A–D
subunits make a tight dimer. Where there are two letters, the first indicates the subunit and the second is the amino acid code followed by the residue number. (a) Position of Ser-74, Arg-81,
Glu-93 and Asp-90 and their interactions in hcSHMT. (b) The position of Trp-111, surrounded by the hydrophobic cluster in hcSHMT. (c) The position of A-subunit Arg-99 and its interaction
with D-subunit Asp-30 in hcSHMT, representing inter-subunit interactions. (d) Interaction of His-151, Asp-228, His-231, Lys-257 and His-357 with PLP at the active site.
mutation should have led to the formation of loose dimers.
However, the R98A SHMT mutant, although very well
expressed, was present in the insoluble form, suggesting that the
disruption of interaction between Arg-98 and Asp-29 (Arg-99
and Asp-30 in hcSHMT) at the tight dimer interface also affected
folding of scSHMT (Tables 2 and 3).
His-304 and Ser-118
His-304 is conserved in eukaryotes but not in prokaryotic
organisms (Table 1) [27], suggesting a possible role for the
residue in the evolution of the tetrameric enzyme. The cor-
responding residue, His-305 in hcSHMT (His-304 in scSHMT),
is positioned to interact with Ser-119 (Ser-118 in scSHMT) from
a neighbouring subunit and is within hydrogen-bonding distance
of the phosphate group of PLP (results not shown) [27]. It is
therefore possible that the mutation of His-304 to Ala in scSHMT
disrupts this interaction, leading to the formation of inactive
dimers (Tables 2 and 3). The three-dimensional structure of
hcSHMT revealed that PLP is present at the tight dimer interface.
Therefore, the disruption of interactions at the tight dimer
interface leads to the formation of inactive dimers, which are
incapable of binding PLP (Tables 2 and 3). On the other hand,
mutation of His-134 involved in the interactions at the loose
dimer interface lead to formation of partially active dimers with
bound PLP [29].
Apart from the residues discussed above, the N-terminal
regions clasp across the ‘ tight dimers ’, conferring stability on
the tetramer [5,7,8]. Earlier work on the deletion mutants
from the N-terminus indicated that the N-terminal arm stabilized
the quaternary structure along with PLP [20], confirming their
role in maintenance of the oligomeric structure.
Role of amino acids interacting with PLP in maintaining the
tetrameric structure
Asp-228 in hcSHMT (Asp-227 in scSHMT), which is H-bonded
to the pyridinium N (Figure 4d), is conserved not only in SHMT
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but in all PLP-dependent fold type I enzymes [25]. The mutation
of the corresponding residue, Asp-227, in scSHMT affects the
binding of PLP, and consequently causes the disruption of
tetrameric enzyme. D227N SHMT mutant did not give the
characteristic absorbance at 425 nm and was present as an
inactive dimer (Tables 2 and 3).
Similarly, mutation of Lys-256 in scSHMT, which anchors the
PLP as an internal aldimine, to Gln}Arg resulted in the formation
of inactive dimer with no PLP bound to it [30]. On the other
hand, mutation of the corresponding residue, Lys-229, in the
dimeric E. coli recombinant SHMT to His}Arg resulted in a loss
of ability to bind PLP and a loss of catalytic activity with no
change in the oligomeric structure. The K229Q mutant of E. coli
recombinant SHMT was able to bind external aldimine and
catalyse a single turnover [31].
The other residues that are involved in the stabilization of the
negative charge on N1 of PLP, in addition to Asp-227 in
scSHMT, are His-150, His-230 and His-356. The corresponding
residues, Asp-228, His-151, His-231 and His-357, in hcSHMT
form a charge relay system as shown in Figure 4(d). Among these
residues, His-231 is directly linked to PLP O-3, whereas His-357
is hydrogen-bonded to His-231, and His-151 is hydrogen-bonded
to Asp-228 (Asp-227 in scSHMT). It has been shown previously
that His-150 in scSHMT participates in the proton-abstraction
step of catalysis [29] and that His-230 facilitates the proton
abstraction [32]. It could be predicted that disruption of these
interactions leads to loss of oligomeric structure and catalysis.
The results presented in Tables 2 and 3 substantiate the above
prediction.
Ser-202 along with His-230 and Lys-256 in scSHMT are within
hydrogen-bonding distance of O-3 of PLP at the active site. The
decreased catalytic activity of S202C in scSHMT and its isolation
as a mixture of tetramers and dimers (Tables 2 and 3) further
confirms that Ser-202 interactions are not as crucial as those of
Asp-227, Lys-256 or His-230 for maintaining PLP at the active
site in scSHMT.
Tyr-72 in scSHMT (Tyr-73 in hcSHMT) is a very well
conserved residue among all SHMT sequences and its hydroxy
group interactswith O-2 of the phosphate group of PLP. Isolation
of the Y72F SHMT mutant as a mixture of tetramers and dimers
with marginal activity highlighted the importance of these
interactions and the role of PLP in maintaining the oligomeric
structure.
Cys-204 is positioned at the beginning of random coil 17 in
hcSHMT and is conserved in all SHMTs. It is pertinent to recall
that earlier studies reported the loss of enzyme activity in the
presence of thiol inhibitors [33] and it was also predicted that
Cys-204 could be involved in the thio-hemiacetal mechanism in
hcSHMT [5]. C203S scSHMT had identical properties to the
wild-type enzyme in its PLP content and H
%
-folate-dependent
reactions (Table 2). The mutant enzyme generated characteristic
intermediates with Gly and H
%
-folate (results not shown). How-
ever, the reaction with d-Ala was faster by an order of magnitude
(0.26 min−" for scSHMT and 3.21 min−" for C203S). The apo-
enzyme of C203S was a dimer and could only be partially
reconstituted (30%) with PLP, whereas the apo-scSHMT exists
as a tetramer and can be reconstituted fully (results not shown).
This observation is in support of the suggestion that this Cys
residue interacts indirectly with PLP [26] and may not be
participating in the thio-hemiacetal mechanism. These results
discussed above revealed that although Tyr-72, Asp-227, Lys-
256, Ser-202, Cys-203 and His-356 in scSHMT are not involved
in subunit interactions, their mutation affected PLP binding,
leading to a loss of oligomeric structure. The observations
reported in this paper identify amino acid residues essential for
maintaining the oligomeric structure through intra- and inter-
subunit interactions and the interactions with PLP at the active
site.
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